Funding Opportunity ID: |
318538 |
Opportunity Number: |
PAS-19-316 |
Opportunity Title: |
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) |
Opportunity Category: |
Discretionary |
Opportunity Category Explanation: |
|
Funding Instrument Type: |
Grant |
Category of Funding Activity: |
Health |
Category Explanation: |
|
CFDA Number(s): |
93.866 |
Eligible Applicants: |
Small businesses |
Additional Information on Eligibility: |
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding announcement for eligibility details |
Agency Code: |
HHS-NIH11 |
Agency Name: |
Department of Health and Human Services National Institutes of Health |
Posted Date: |
Jul 18, 2019 |
Close Date: |
Sep 06, 2022 |
Last Updated Date: |
Jul 18, 2019 |
Award Ceiling: |
$0 |
Award Floor: |
$0 |
Estimated Total Program Funding: |
|
Expected Number of Awards: |
|
Description: |
This Funding Opportunity Announcement (FOA) invites applications to NIA's Small Business Innovation Research (SBIR) program to conduct research leading to the development of innovative products and/or services that may advance progress in preventing and treating Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD) and/or caring for and treating AD/ADRD patients. |
Version: |
1 |